The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Varicella Prevention in the United States: A Review of Successes and Challenges
Abstract
OBJECTIVE. In 1995, the United States was the first country to introduce a universal 1-dose childhood varicella vaccination program. In 2006, the US varicella vaccine policy was changed to a routine 2-dose childhood program, with catchup vaccination for older children. The objective of this review was to summarize the US experience with the 1-dose varicella vaccination program, present the evidence considered for the policy change, and outline future challenges of the program. METHODS. We conducted a review of publications identified by searching PubMed for the terms “varicella,” “varicella vaccine,” and “herpes zoster.” The search was limited to US publications except for herpes zoster; we reviewed all published literature on herpes zoster incidence. RESULTS. A single dose of varicella vaccine was 80% to 85% effective in preventing disease of any severity and >95% effective in preventing severe varicella and had an excellent safety profile. The vaccination program reduced disease incidence by 57% to 90%, hospitalizations by 75% to 88%, deaths by >74%, and direct inpatient and outpatient medical expenditures by 74%. The decline of cases plateaued between 2003 and 2006, and outbreaks continued to occur, even among highly vaccinated school populations. Compared with children who received 1 dose, in 1 clinical trial, 2-dose vaccine recipients developed in a larger proportion antibody titers that were more likely to protect against breakthrough disease and had a 3.3-fold lower risk for breakthrough disease and higher vaccine efficacy. Two studies showed no increase in overall herpes zoster incidence, whereas 2 others showed an increase. CONCLUSIONS. A decade of varicella prevention in the United States has resulted in a dramatic decline in disease; however, even with high vaccination coverage, the effectiveness of 1 dose of vaccine did not generate sufficient population immunity to prevent community transmission. A 2-dose varicella vaccine schedule, therefore, was recommended for children in 2006. Data are inconclusive regarding an effect of the varicella vaccination program on herpes zoster epidemiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Summary of notifiable diseases--United States, 2002.
Groseclose, S. L., Brathwaite, W. S., Hall, P. A., Connor, F. J., Sharp, P., Anderson, W. J., Fagan, R. F., Javier, A. J., Jones, G. F., Nitschke, D. A., et al. (2004) · MMWR Morbidity and Mortality Weekly Report · Cited by 1,379
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
(1996) · PsycEXTRA Dataset · doi:10.1037/e547262006-001 · Cited by 1,079
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,037
Self-citationPopulation-Based Study of Herpes Zoster and Its Sequelae
RAGOZZINO, M. W., MELTON, L. J., KURLAND, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 926
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
The Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.15.1605 · Cited by 652
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
Seward, J. F. (2002) · JAMA · doi:10.1001/jama.287.5.606 · Cited by 557
Self-citationThe incidence of herpes zoster in a United States administrative database
Insinga, R. P., Itzler, R. F., Pellissier, J. M., Saddier, P., & Nikas, A. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0150.x · Cited by 490
Hardy, I., Gershon, A. A., Steinberg, S. P., & LaRussa, P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111283252204 · Cited by 452
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
BRISSON, M., EDMUNDS, W. J., LAW, B., GAY, N. J., WALLD, R., BROWNELL, M., ROOS, L. L., & DE SERRES, G. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005921 · Cited by 432
Nguyen, H. Q., Jumaan, A. O., & Seward, J. F. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042271 · Cited by 412
Self-citationBrisson, M., Gay, N. J., Edmunds, W. J., & Andrews, N. J. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00180-9 · Cited by 341
Loss of Vaccine-Induced Immunity to Varicella over Time
Chaves, S. S., Gargiullo, P., Zhang, J. X., Civen, R., Guris, D., Mascola, L., & Seward, J. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064040 · Cited by 315
Self-citationJumaan, A. O., Yu, O., Jackson, L. A., Bohlke, K., Galil, K., & Seward, J. F. (2005) · The Journal of Infectious Diseases · doi:10.1086/430325 · Cited by 285
Self-citationEffectiveness Over Time of Varicella Vaccine
Vázquez, M. (2004) · JAMA · doi:10.1001/jama.291.7.851 · Cited by 282
Varicella Mortality: Trends before Vaccine Licensure in the United States, 1970–1994
Meyer, P. A., Seward, J. F., Jumaan, A. O., & Wharton, M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315714 · Cited by 279
Self-citationThomas, S. L., Wheeler, J. G., & Hall, A. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09837-9 · Cited by 262
The postmarketing safety profile of varicella vaccine
Sharrar, R. G., LaRussa, P., Galea, S. A., Steinberg, S. P., Sweet, A. R., Keatley, R. M., Wells, M. E., Stephenson, W. P., & Gershon, A. A. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00297-8 · Cited by 253
Impact of Varicella Vaccination on Health Care Utilization
Zhou, F. (2005) · JAMA · doi:10.1001/jama.294.7.797 · Cited by 245
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200205000-00020 · Cited by 233
Postlicensure Safety Surveillance for Varicella Vaccine
Wise, R. P. (2000) · JAMA · doi:10.1001/jama.284.10.1271 · Cited by 213
Davis, M. M., Patel, M. S., & Gebremariam, A. (2004) · Pediatrics · doi:10.1542/peds.2004-0012 · Cited by 205
Yih, W. K., Brooks, D. R., Lett, S. M., Jumaan, A. O., Zhang, Z., Clements, K. M., & Seward, J. F. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-68 · Cited by 203
Self-citationHospitalizations for varicella in the United States, 1988 to 1999
GALIL, K., BROWN, C., LIN, F., & SEWARD, J. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00009 · Cited by 202
Self-citationContagiousness of Varicella in Vaccinated Cases: A Household Contact Study
Seward, J. F., Zhang, J. X., Maupin, T. J., Mascola, L., & Jumaan, A. O. (2004) · JAMA · doi:10.1001/jama.292.6.704 · Cited by 195
Self-citationWHITE, C. J., KUTER, B. J., NGAI, A., HILDEBRAND, C. S., ISGANITIS, K. L., PATTERSON, C. M., CAPRA, A., MILLER, W. J., KRAH, D. L., PROVOST, P. J., et al. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199201000-00006 · Cited by 182
Varicella in Americans from NHANES III: Implications for control through routine immunization
Kilgore, P. E., Kruszon-Moran, D., Seward, J. F., Jumaan, A., Van Loon, F. P. L., Forghani, B., McQuillan, G. M., Wharton, M., Fehrs, L. J., Cossen, C. K., et al. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10364 · Cited by 172
Self-citationIncidence of herpes zoster, 1997–2002
MULLOOLY, J. P., RIEDLINGER, K., CHUN, C., WEINMANN, S., & HOUSTON, H. (2005) · Epidemiology and Infection · doi:10.1017/s095026880400281x · Cited by 165
Tsolia, M., Gershon, A. A., Steiberg, S. P., & Gelb, L. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82872-0 · Cited by 158
Verstraeten, T., Jumaan, A. O., Mullooly, J. P., Seward, J. F., Izurieta, H. S., Destefano, F. R., BLACK, S. B., & Chen, R. T. (2003) · PEDIATRICS · doi:10.1542/peds.112.2.e98 · Cited by 144
Self-citationPrimary Vaccine Failure after 1 Dose of Varicella Vaccine in Healthy Children
Michalik, D. E., Steinberg, S. P., LaRussa, P. S., Edwards, K. M., Wright, P. F., Arvin, A. M., Gans, H., & Gershon, A. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/529043 · Cited by 140
Chaves, S. S., Haber, P., Walton, K., Wise, R. P., Izurieta, H. S., Schmid, D. S., & Seward, J. F. (2008) · The Journal of Infectious Diseases · doi:10.1086/522161 · Cited by 132
Self-citationLi, S., CHAN, A. S. F., Matthews, H., Heyse, J. F., Chan, C. Y., Kuter, B. J., Kaplan, K. M., VESSEY, S. J. R., & SADOFF, J. C. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200204000-00014 · Cited by 126
Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children
Shinefield, H. R., BLACK, S. B., Digilio, L., Reisinger, K. S., Blatter, M. M., Gress, J., Brown, M. L. H., Eves, K. A., Klopfer, S. O., Schödel, F. P., et al. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000172902.25009.a1 · Cited by 125
Community impact of childhood varicella infections
Yawn, B. P., Yawn, R. A., & LYDICK, E. G. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)80019-4 · Cited by 110
An Outbreak of Varicella among Children Attending Preschool and Elementary School in Illinois
Dworkin, M. S., Jennings, C. E., Roth‐Thomas, J., Lang, J. E., Stukenberg, C., & Lumpkin, J. R. (2002) · Clinical Infectious Diseases · doi:10.1086/340868 · Cited by 93
Nader, S., Bergen, R., Sharp, M. A., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.13 · Cited by 90
An Economic Analysis of the Universal Varicella Vaccination Program in the United States
Zhou, F., Ortega‐Sanchez, I. R., Güriş, D., Shefer, A. M., Lieu, T. A., & Seward, J. F. (2008) · The Journal of Infectious Diseases · doi:10.1086/522135 · Cited by 83
Self-citationSecular trends in the epidemiology of shingles in Alberta
RUSSELL, M. L., Schopflocher, D., Svenson, L. W., & VIRANI, S. N. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807007893 · Cited by 76
Metaanalysis of vaccine effectiveness in varicella outbreaks
Bayer, O., Heininger, U., Heiligensetzer, C., & von Kries, R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.010 · Cited by 70
Secondary transmission of varicella vaccine virus in a chronic care facility for children
Grossberg, R., Harpaz, R., Rubtcova, E. N., et al. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.038 · Cited by 44
Varicella-related hospitalizations in the vaccine era
Ratner, A. J. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00008 · Cited by 42
Gershon, A. A., Takahashi, M., & Seward, J. F. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50039-8 · Cited by 21
Self-citation
Cited by
Pijpers, M. A. M., Tabbers, M. M., Benninga, M. A., & Berger, M. Y. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.127233 · Cited by 187
Metadata
- Authors
- Marin, M., Meissner, H. C., & Seward, J. F.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-09-01
- Volume
- 122
- Issue
- 3
- Pages
- e744-e751
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1993113905
- Cited by
- 269
- References
- 48
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.